标题
EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesis
作者
关键词
-
出版物
CANCER AND METASTASIS REVIEWS
Volume 31, Issue 3-4, Pages 753-761
出版商
Springer Nature
发表日期
2012-06-18
DOI
10.1007/s10555-012-9387-3
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Antiangiogenic agents in advanced gastrointestinal malignancies: past, present and a novel future
- (2015) Oncotarget
- miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis
- (2015) Oncotarget
- Cancer stem cells and EMT in carcinoma
- (2012) Adrian Biddle et al. CANCER AND METASTASIS REVIEWS
- Cancer stem cells and tumor angiogenesis
- (2012) Domenico Ribatti CANCER LETTERS
- Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer
- (2012) Harry D. Bear et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neoadjuvant Chemotherapy and Bevacizumab for HER2-Negative Breast Cancer
- (2012) Gunter von Minckwitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Role of EZH2 in the Regulation of the Activity of Matrix Metalloproteinases in Prostate Cancer Cells
- (2012) Yong Jae Shin et al. PLoS One
- Loss of Let-7 Up-Regulates EZH2 in Prostate Cancer Consistent with the Acquisition of Cancer Stem Cell Signatures That Are Attenuated by BR-DIM
- (2012) Dejuan Kong et al. PLoS One
- Role of BMI1, a Stem Cell Factor, in Cancer Recurrence and Chemoresistance: Preclinical and Clinical Evidences
- (2012) Hifzur Rahman Siddique et al. STEM CELLS
- FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells
- (2011) Juan Du et al. BREAST CANCER RESEARCH AND TREATMENT
- Coordinated Regulation of Polycomb Group Complexes through microRNAs in Cancer
- (2011) Qi Cao et al. CANCER CELL
- EZH2 Promotes Expansion of Breast Tumor Initiating Cells through Activation of RAF1-β-Catenin Signaling
- (2011) Chun-Ju Chang et al. CANCER CELL
- (-)-Epigallocatechin-3-gallate and DZNep reduce polycomb protein level via a proteasome-dependent mechanism in skin cancer cells
- (2011) S. R. Choudhury et al. CARCINOGENESIS
- Anchorage-independent cytokinesis as part of oncogenic transformation?
- (2011) Minna Thullberg et al. CELL CYCLE
- Phosphorylation of EZH2 by CDK1 and CDK2
- (2011) Xianzhuo Zeng et al. CELL CYCLE
- Polycomb protein EZH2 regulates cancer cell fate decision in response to DNA damage
- (2011) Z Wu et al. CELL DEATH AND DIFFERENTIATION
- Polycomb Repressor Complex-2 Is a Novel Target for Mesothelioma Therapy
- (2011) C. D. Kemp et al. CLINICAL CANCER RESEARCH
- Polycomb genes and cancer: Time for clinical application?
- (2011) Francesco Crea et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Loading 3-deazaneplanocin A into pegylated unilamellar liposomes by forming transient phenylboronic acid–drug complex and its pharmacokinetic features in Sprague–Dawley rats
- (2011) Feng Sun et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2
- (2011) Fang Zheng et al. GUT
- 3-Deazaneplanocin A is a promising therapeutic agent for the eradication of tumor-initiating hepatocellular carcinoma cells
- (2011) Tetsuhiro Chiba et al. INTERNATIONAL JOURNAL OF CANCER
- Pharmacologic disruption of Polycomb Repressive Complex 2 inhibits tumorigenicity and tumor progression in prostate cancer
- (2011) Francesco Crea et al. Molecular Cancer
- Metastasis: new perspectives on an old problem
- (2011) Sandra Kraljevic Pavelic et al. Molecular Cancer
- FGF-2 Regulates Cell Proliferation, Migration, and Angiogenesis through an NDY1/KDM2B-miR-101-EZH2 Pathway
- (2011) Filippos Kottakis et al. MOLECULAR CELL
- Tumor angiogenesis: molecular pathways and therapeutic targets
- (2011) Sara M Weis et al. NATURE MEDICINE
- MEK–ERK pathway regulates EZH2 overexpression in association with aggressive breast cancer subtypes
- (2011) S Fujii et al. ONCOGENE
- Down-Regulation of miR-101 in Endothelial Cells Promotes Blood Vessel Formation through Reduced Repression of EZH2
- (2011) Michiel Smits et al. PLoS One
- MicroRNAs in the Pathogenesis of Cancer
- (2011) Francesca Lovat et al. SEMINARS IN ONCOLOGY
- Should progression-free survival be the primary measure of efficacy for advanced NSCLC therapy?
- (2010) J. C. Soria et al. ANNALS OF ONCOLOGY
- S-adenosylhomocysteine hydrolase inhibition by 3-deazaneplanocin A analogues induces anti-cancer effects in breast cancer cell lines and synergy with both histone deacetylase and HER2 inhibition
- (2010) Annette Hayden et al. BREAST CANCER RESEARCH AND TREATMENT
- Bevacizumab in metastatic breast cancer: a meta-analysis of randomized controlled trials
- (2010) A. Valachis et al. BREAST CANCER RESEARCH AND TREATMENT
- Decreased expression of EZH2 is associated with upregulation of ER and favorable outcome to tamoxifen in advanced breast cancer
- (2010) E. A. Reijm et al. BREAST CANCER RESEARCH AND TREATMENT
- Panobinostat treatment depletes EZH2 and DNMT1 levels and enhances decitabine mediated de-repression of JunB and loss of survival of human acute leukemia cells
- (2010) Warren Fiskus et al. CANCER BIOLOGY & THERAPY
- Regulation of Tumor Angiogenesis by EZH2
- (2010) Chunhua Lu et al. CANCER CELL
- Stage II and Stage III Colon Cancer
- (2010) Benoît Rousseau et al. CANCER JOURNAL
- Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer
- (2010) B. Zhang et al. CARCINOGENESIS
- Ixabepilone Plus Capecitabine for Breast Cancer Patients With an Early Metastatic Relapse After Adjuvant Chemotherapy: Two Clinical Trials
- (2010) Monica Fornier Clinical Breast Cancer
- Hypoxia and Hypoxia-Inducible Factors: Master Regulators of Metastasis
- (2010) X. Lu et al. CLINICAL CANCER RESEARCH
- MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion
- (2010) Hui-Ju Wang et al. EUROPEAN JOURNAL OF CANCER
- Biomarkers to predict the clinical efficacy of bevacizumab in cancer
- (2010) Adrian M Jubb et al. LANCET ONCOLOGY
- Clinical significance of Polycomb gene expression in brain tumors
- (2010) Francesco Crea et al. Molecular Cancer
- Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells
- (2010) Lucia Ricci-Vitiani et al. NATURE
- An oncogene–tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-κB
- (2010) Junxia Min et al. NATURE MEDICINE
- EZH2 and STAT6 expression profiles are correlated with colorectal cancer stage and prognosis
- (2010) Cheng-Gang Wang WORLD JOURNAL OF GASTROENTEROLOGY
- Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells
- (2009) W. Fiskus et al. BLOOD
- Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
- (2009) John M.L. Ebos et al. CANCER CELL
- EZH2 Is Essential for Glioblastoma Cancer Stem Cell Maintenance
- (2009) M.-L. Suva et al. CANCER RESEARCH
- Transient RNA silencing of tissue factor pathway inhibitor-2 modulates lung cancer cell invasion
- (2009) Sophie Iochmann et al. CLINICAL & EXPERIMENTAL METASTASIS
- Epigenetic gene regulation in stem cells and correlation to cancer
- (2009) Lesley A. Mathews et al. DIFFERENTIATION
- DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation
- (2009) T. B. Miranda et al. MOLECULAR CANCER THERAPEUTICS
- Low-dose metronomic cyclophosphamide combined with vascular disrupting therapy induces potent antitumor activity in preclinical human tumor xenograft models
- (2009) L. G. Daenen et al. MOLECULAR CANCER THERAPEUTICS
- Molecular mechanisms of metastasis
- (2008) Georg F. Weber CANCER LETTERS
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
- Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
- (2008) R. W. Tothill et al. CLINICAL CANCER RESEARCH
- Synergistic Antitumor Activity of Ixabepilone (BMS-247550) Plus Bevacizumab in Multiple In vivo Tumor Models
- (2008) F. Y.F. Lee et al. CLINICAL CANCER RESEARCH
- Pathways Mediating Resistance to Vascular Endothelial Growth Factor-Targeted Therapy
- (2008) L. M. Ellis et al. CLINICAL CANCER RESEARCH
- Cancer Stem Cells: The Seeds of Metastasis?
- (2008) E. M. Hurt et al. MOLECULAR INTERVENTIONS
- Tumor Angiogenesis
- (2008) Robert S. Kerbel NEW ENGLAND JOURNAL OF MEDICINE
- Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer
- (2008) S. Varambally et al. SCIENCE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started